Methodist Dallas Medical Center
Dallas, Texas, 75201, United States
Completed
NCT Number: NCT06223620
A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction
The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–89 year
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress. Plan to perform a retrospective review of management protocols at these institutions. Wish to know whether the implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
The objective of the study is to review performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress.
Hypothesize that implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- • Adults aged 18-89 years of age
- Patients presenting with SBO
Exclusion criteria
- • Prisoners
- Pregnant women
Treatment and study plan
review performance of water soluble contrast
Otherreview performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.
Primary outcomes
-
Morbidity and length of stay
Time frame: 1 year
Morbidity and length of stay
Secondary outcomes
-
Patient demographics
Time frame: 1 year
number of patients (age, sex, weight, height)
-
admit date
Time frame: 1 year
Number of patients admitting to the hospital
-
discharge date
Time frame: 1 year
number of patients discharging
-
admission service
Time frame: 1 year
Number of services related to admissions
-
Aspirin(ASA )class
Time frame: 1 year
number of aspirin class
-
comorbidities
Time frame: 1 year
number of comorbidities associated
-
surgical history
Time frame: 1 year
number of surgeries in the past
-
labs
Time frame: 1 year
number of labs done
-
time of contrast given
Time frame: 1 year
rate of Contrast given
Sponsors and collaborators
Lead sponsor
Methodist Health System
Other
Registry information
Important dates
- Study start
- 2018
- Primary completion
- 2019
- Study completion
- 2019
- First posted
- Jan 25, 2024
- Registry last updated
- Mar 24, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.